Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma
Cancer Reports · 2025
DOI: 10.1002/cnr2.70345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Takahiro Iwamoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Receptor, Notch1, Mouth Neoplasms, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Notch1 , a tumor suppressor gene, is one of the most frequently mutated genes in head and neck squamous cell carcinoma (HNSCC). Therefore, it is clinically important to investigate the effects of Notch1 mutations on antitumor immunity in oral squamous cell carcinoma (OSCC), a subset of HNSCC.
Aims
This study investigated Notch1 mutations and the expression of immune‐related proteins. We also examined the influence of Notch1 mutations on the immune microenvironment using a public database. Methods and Results We examined the expression of Notch1–4 in OSCC cell lines using qPCR. After Notch1 knockdown, OSCC cell proliferation and migration were analyzed using CCK8 and wound healing assays, respectively. Localization of programmed cell death ligand 1 (PD‐L1) was assessed by western blot and flow cytometry, while PD‐L1 expression was evaluated by western blot. In the somatic mutation analysis of 47 OSCC patients, the relationship between tumor‐infiltrating CD8 + T cells and PD‐L1 expression was analyzed using immunohistochemical (IHC) staining. Furthermore, data from The Cancer Genome Atlas (TCGA) were analyzed using multiple online bioinformatics tools to compare the characteristics of Notch1 mutations in HNSCC. The expression of Notch1 varied depending on the OSCC cell line phenotype, and Notch1 mutation was significantly correlated with tumor growth but not with tumor infiltration. In Notch1 knockdown, PD‐L1 expression on the tumor cell surface increased, while cytoplasmic PD‐L1 expression decreased. Among the 47 OSCC patients analyzed, seven (14%) had Notch1 mutations. Of those, five patients (71%) exhibited high tumor‐infiltrating CD8 + T cells and Notch1 mutation. Online bioinformatics analysis using the xCell algorithm revealed that Notch1‐mutated tumors had significantly higher levels of naïve CD8 + T cells compared to Notch1 wild‐type tumors.
Conclusion
These findings highlight Notch1 mutation as a potential therapeutic target for immune recognition in OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Surgery, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Department of Surgical Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Biology Division, Department of Liberal Arts and Sciences, Center for Medical Education, Sapporo Medical University, Sapporo, Japan.
ORCID-Profile: Takahiro Iwamoto, Kazuhiro Ogi, Sho Miyamoto, Kenta Sasaki, Yasushi Sasaki, Akihiro Miyazaki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Iwamoto, T., Ogi, K., Nakagaki, T., Sasaya, T., Miyamoto, S., Nishiyama, K., Sasaki, K., Sugita, S., Sasaki, Y., & Miyazaki, A. (2025). Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma. Cancer Reports. https://doi.org/10.1002/cnr2.70345
Vancouver
Iwamoto T, Ogi K, Nakagaki T, Sasaya T, Miyamoto S, Nishiyama K, et al. Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma. Cancer Reports. 2025. doi:10.1002/cnr2.70345
BibTeX
@article{Iwamoto2025,
author = {Iwamoto, Takahiro and Ogi, Kazuhiro and Nakagaki, Takafumi and Sasaya, Takashi and Miyamoto, Sho and Nishiyama, Koyo and Sasaki, Kenta and Sugita, Shintaro and Sasaki, Yasushi and Miyazaki, Akihiro},
title = {Notch1 Mutation Represents a Potential Therapeutic Target to Enhance Immune Recognition in Oral Squamous Cell Carcinoma},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70345}
}
EUVIMED